These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 16356709)
1. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer. Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709 [TBL] [Abstract][Full Text] [Related]
2. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy. Tanaka M; Kitajima Y; Sato S; Miyazaki K Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583 [TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma. Ando H; Aihara R; Ohno T; Ogata K; Mochiki E; Kuwano H Br J Surg; 2009 Aug; 96(8):901-9. PubMed ID: 19591170 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract. Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728 [TBL] [Abstract][Full Text] [Related]
6. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival]. Zhou YN; Li M Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049 [TBL] [Abstract][Full Text] [Related]
7. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy. Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743 [TBL] [Abstract][Full Text] [Related]
9. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma. Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395 [TBL] [Abstract][Full Text] [Related]
10. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730 [TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319 [TBL] [Abstract][Full Text] [Related]
12. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. Liu J; Ikeguchi M; Nakamura S; Kaibara N J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532 [TBL] [Abstract][Full Text] [Related]
13. Expression of sialylated MUC1 in prostate cancer: relationship to clinical stage and prognosis. Arai T; Fujita K; Fujime M; Irimura T Int J Urol; 2005 Jul; 12(7):654-61. PubMed ID: 16045558 [TBL] [Abstract][Full Text] [Related]
14. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis. Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin. Kigure S Rinsho Byori; 2006 May; 54(5):447-52. PubMed ID: 16789413 [TBL] [Abstract][Full Text] [Related]
17. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope. Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224 [TBL] [Abstract][Full Text] [Related]
18. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas. Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785 [TBL] [Abstract][Full Text] [Related]